Budapest, Hungary

Elemér Fogassy

This inventor holds 1 USPTO granted patent and 1 published patent application and 5 EPO patents. Top assignee: Sanofi-Aventis. Active years: 2008.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elemér Fogassy: Innovator in Pharmaceutical Chemistry

Introduction

Elemér Fogassy is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative approaches to drug resolution processes. His work has implications for the development of important pharmaceutical compounds.

Latest Patents

Fogassy holds a patent for a resolution process for (R)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid. This invention focuses on the preparation of the (R)-(-)-2-hydroxy-2-(2-chlorophenyl)acetic acid by resolving the corresponding racemic compound using specific compounds. This patent highlights his expertise in creating effective methods for synthesizing complex chemical compounds.

Career Highlights

Throughout his career, Elemér Fogassy has been associated with Sanofi-Aventis, a leading global pharmaceutical company. His work at Sanofi-Aventis has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his research and innovations.

Collaborations

Fogassy has worked alongside notable colleagues such as József Bálint and Marianna Csatáriné Nagy. These collaborations have contributed to the advancement of pharmaceutical research and the development of new therapeutic solutions.

Conclusion

Elemér Fogassy's contributions to pharmaceutical chemistry through his innovative patent and collaborations with esteemed colleagues underscore his importance in the field. His work continues to influence the development of effective pharmaceutical compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…